220
Participants
Start Date
October 31, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
March 31, 2014
Low dose RSV-F Vaccine with Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)
0.5mL IM injections
Low dose RSV-F Vaccine without Adjuvant (Day 0); Seasonal TIV (Day 0 & day 28)
0.5mL IM injections
High dose RSV-F Vaccine with Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)
0.5mL IM injections
High dose RSV-F Vaccine without Adjuvant (Day 0); Seasonal TIV (Day 0 & Day 28)
0.5mL IM injections
Placebo (Day 0 & Day 28); Seasonal TIV (Day 0)
0.5mL IM Injections
Accelovance, Melbourne
Research Across America, Dallas
Jean Brown Research, Salt Lake City
Genova Clinical Research, Tucson
Lead Sponsor
Novavax
INDUSTRY